脑干肿瘤的新治疗方法:在动物模型中使用纳米脂质体伊立替康比较不同给药途径
研究在大鼠脑干肿瘤异种移植模型中比较了纳米脂质体伊立替康经对流增强递送(CED)、鼻内递送(IND)和静脉注射(IV)的效果。单次CED与多次IV对总生存影响相似,IND显著延长生存,显示非侵入性绕过血脑屏障联合纳米脂质体化疗的前景。
要点
- 单次CED与多次IV的纳米脂质体伊立替康对脑干肿瘤大鼠总生存影响相似。
- 鼻内递送纳米脂质体伊立替康显著延长脑干肿瘤大鼠生存。
- CED和IND递送纳米脂质体治疗增加脑干胶质瘤实用治疗方法的可能性。
核心结论
- 单次CED与多次IV的纳米脂质体伊立替康对脑干肿瘤大鼠总生存影响相似。
- IND纳米脂质体伊立替康显著延长脑干肿瘤大鼠生存。
- CED和IND递送纳米脂质体治疗增加脑干胶质瘤实用治疗方法的可能性。
研究设计与样本
- 研究使用携带人脑干肿瘤异种移植的大鼠,分别经CED、IND和IV给予纳米脂质体伊立替康(CPT-11)治疗。
主要发现
- 单次CED伊立替康对总生存的影响与多次IV途径相似。
- IND CPT-11显示脑干肿瘤动物生存显著增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite the advances in imaging, surgery and radiotherapy, the majority of patients with brainstem gliomas die within 2 years after initial diagnosis. Factors that contribute to the dismal prognosis of these patients include the infiltrative nature and anatomic location in an eloquent area of the brain, which prevents total surgical resection and the presence of the blood-brain barrier (BBB), which reduces the distribution of systemically administered agents. The development of new therapeutic approaches which can circumvent the BBB is a potential path to improve outcomes for these children. Convection-enhanced delivery (CED) and intranasal delivery (IND) are strategies that permit direct drug delivery into the central nervous system and are an alternative to intravenous injection (IV). We treated rats bearing human brainstem tumor xenografts with nanoliposomal irinotecan (CPT-11) using CED, IND, and IV. A single treatment of CED irinotecan had a similar effect on overall survival as multiple treatments by IV route. IND CPT-11 showed significantly increased survival of animals with brainstem tumors, and demonstrated the promise of this non-invasive approach of drug delivery bypassing the BBB when combined with nanoliposomal chemotherapy. Our results indicated that using CED and IND of nanoliposomal therapy increase likelihood of practical therapeutic approach for the treatment of brainstem gliomas.
引用
- Louis N, Liu S, He X, et al. New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model. J Neurooncol. 2017. PMID: 29170909. doi:10.1007/s11060-017-2681-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。